PDSB · PDS Biotechnology Corp
United States · RS rating 98 · As of 2026-11-03
| Price | 1.41 USD |
|---|---|
| 1-day change | +2.9% |
| RS rating (overall / 1M / 3M / 12M) | 98 / 92 / 97 / 85 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 36 / 66 / 58 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -38.5% |
| Sales growth Q/Q | – |
| Distance from 52-week high | +11.9% |
| Market cap (USD) | $51.8M |